Metrics In Balance (MLMIB) | Stock Overview & Key Data
Metrics In Balance S.A. | Small-cap | Healthcare
Metrics In Balance S.A. | Small-cap | Healthcare
Metrics In Balance Performance Comparison
Stock Range
Today's Range
Low: €0.03
High: €0.03
on August 21, 2025
52 Week Range
Low: €0.03
High: €0.03
on August 21, 2025
on August 21, 2025
All-Time High: €7.50 on May 13, 2019
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Market Cap
€790.3K
EPS
-0.01
P/E Ratio (TTM)
N/A
Forward P/E
N/A
P/B Ratio
0.01
PEG Ratio
N/A
Div. Yield
N/A
ROE
-0.45%
Beta
0.159
Debt to Equity
N/A
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
-15,429.00%
Profit Margin
-17,317.00%
Returns and Earnings
Return on Assets (TTM)
-0.23%
Return on Equity (TTM)
-0.45%
EBITDA
€-39.6K
Net Income (TTM)
€-53.5K
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€0.00
Quarterly Revenue Growth (YoY)
N/A
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Metrics In Balance MLMIB | 790.30K Small-cap | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -90.00% | -98.99% |
| Bastide le Confort BLC | 207.60M Mid-cap | 2.71% | -7.34% | -2.74% | 8.40% | 20.85% | 30.88% | -23.24% | -36.47% |
| Laboratoires ALEMG | 12.06M Small-cap | -1.40% | -3.20% | 3.68% | 0.71% | -3.64% | -19.89% | -28.91% | -53.77% |
| EssilorLuxottica EL | 126.95B Large-cap | 1.68% | 12.26% | 3.58% | -5.36% | 16.14% | 26.57% | 79.07% | 139.75% |
| Sartorius Stedim DIM | 17.57B Large-cap | 0.25% | 1.63% | -9.07% | -12.99% | -3.92% | 0.23% | -53.00% | -40.00% |
| bioMérieux S.A BIM | 15.02B Large-cap | 1.19% | 6.97% | 7.78% | 11.46% | 24.05% | 23.21% | 21.51% | 1.92% |
Ownership & Short Interest
Insider Ownership
N/A
Institutional Ownership
N/A
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
400
Average 90-Day Volume
133
Metrics In Balance Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Metrics In Balance would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is MLMIB's 52-week high and low?
- In the last 52 weeks, Metrics In Balance reached a high of €0.03 (on August 21, 2025) and a low of €0.03 (on August 21, 2025).
- What is the market cap and P/E ratio for MLMIB?
- Curious about Metrics In Balance's size and valuation? Its market capitalization stands at 790.30K. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is N/A.
- Does MLMIB pay dividends? If so, what's the yield?
- As for dividends, Metrics In Balance isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Metrics In Balance's main competitors or similar companies to consider before investing?
When looking at Metrics In Balance, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Bastide le Confort
BLC207.60M Healthcare Medical Distribution 30.88% -23.24% Laboratoires
ALEMG12.06M Healthcare Medical Distribution -19.89% -28.91% EssilorLuxottica
EL126.95B Healthcare Medical Instruments & Supplies 26.57% 79.07% Sartorius Stedim
DIM17.57B Healthcare Medical Instruments & Supplies 0.23% -53.00% bioMérieux S.A
BIM15.02B Healthcare Diagnostics & Research 23.21% 21.51% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Metrics In Balance S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Metrics In Balance's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -0.45%, the Debt to Equity ratio from the most recent quarter is N/A, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for MLMIB?
- Looking at Metrics In Balance's growth, its revenue over the trailing twelve months (TTM) was €300. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of MLMIB stock is held by insiders and institutions?
- Wondering who owns Metrics In Balance stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.